Ingredients:CarnipureTM *** 1,100 mg ** (L-Carnitine),Pantothenic Acid 10 mg (as calcium pantothenate)Purified water, glycerin, hydroxy-citric acid
You should contact a doctor or seek emergency care if you experience: Difficulty breathing or swallowing Significant facial or throat swelling Persistent or worsening injection-site reactions (such as increasing pain, pus, or red streaks) Severe, unusual, or unexpected symptoms after use Signs of systemic illness like extreme fatigue, jaundice (yellowing of the skin or eyes), or neurological changes, which could indicate severe copper imbalance
Virji A (2019)
Skip alcohol and caffeine : Avoid these for at least 24 hours before your procedure to minimize blood flow
KW-6356 is a second-generation A2A antagonist which has shown positive results with regard to motor progression in early-stage PD, as assessed by changes in the MDS-UPDRS motor score from baseline until the end of follow-up, both in combination with levodopa (NCT03703570) and as monotherapy (NCT02939391, Table 2) (Chen et al
In clinical trials, including a Phase 2 study published in the New England Journal of Medicine (2023), it has been administered as a subcutaneous injection injected beneath the skin typically once weekly